Metraipolis › archive › dc_bb86021ffb38

Utility of [99mTc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a… — Europe PMC PMID:40913745

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40913745
DOI
10.1007/s00262-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-10T02:36:16.401Z
SHA-256 of the archived text
891dbfc1dc9c8c74e2824060f863f9e9493e788b2c71b01265558ed336dfe2b8
Stable URL of this page
https://metraipolis.com/documento/dc_bb86021ffb38

How to cite

Utility of [99mTc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a… — Europe PMC PMID:40913745 — Europe PMC (en), https://europepmc.org/article/MED/40913745 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb86021ffb38 (Metraipolis archive dc_bb86021ffb38, sha256 891dbfc1dc9c8c74e2824060f863f9e9493e788b2c71b01265558ed336dfe2b8)
BibTeX
@misc{dcbb86021ffb38,
  title = {Utility of [99mTc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a… — Europe PMC PMID:40913745},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40913745},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb86021ffb38; sha256 891dbfc1dc9c8c74e2824060f863f9e9493e788b2c71b01265558ed336dfe2b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40913745. Agents can read the archived copy with the MCP tool read_document.